Evidence map›Paper›PMID 28577909›Full record

ArticleMechanisms of development2017

SOX7 expression is critically required in FLK1-expressing cells for vasculogenesis and angiogenesis during mouse embryonic development.

Andrew J Lilly, Andrzej Mazan, Daryl A Scott, Georges Lacaud, Valerie Kouskoff

Open access · hybridAbstract read
In one paragraph

Article in Mechanisms of development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Transcription factors regulating vasculogenesis and angiogenesis.Developmental dynamics : an official publication of the American Association of Anatomists · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Connection between SOX7 Expression and Breast Cancer Prognosis.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  17. Article
  18. Stem cells and development · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Andrew J LillyCancer Research UK Manchester Institute, The University of Manchester, Wilmslow road, M20 4BX, UK.
Andrzej MazanCancer Research UK Manchester Institute, The University of Manchester, Wilmslow road, M20 4BX, UK.
Daryl A ScottDepartment of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, BCM227, Houston, TX 77030, USA.
Georges LacaudCancer Research UK Manchester Institute, The University of Manchester, Wilmslow road, M20 4BX, UK. Electronic address: georges.lacaud@cruk.manchester.ac.uk.
Valerie KouskoffCancer Research UK Manchester Institute, The University of Manchester, Wilmslow road, M20 4BX, UK; Division of Developmental Biology and Medicine, The University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK. Electronic address: valerie.kouskoff@manchester.ac.uk.
University of Manchester · GBBaylor College of Medicine · US

Funding

Biotechnology and Biological Sciences Research Council BB/I001794/1Cancer Research UK 12486Cancer Research UK 12487Cancer Research UK 19565Cancer Research UK C5759/A20971Medical Research Council MR/P000673/1
6 · The paper itself

Abstract

The transcriptional program that regulates the differentiation of endothelial precursor cells into a highly organized vascular network is still poorly understood. Here we explore the role of SOX7 during this process, performing a detailed analysis of the vascular defects resulting from either a complete deficiency in Sox7 expression or from the conditional deletion of Sox7 in FLK1-expressing cells. We analysed the consequence of Sox7 deficiency from E7.5 onward to determine from which stage of development the effect of Sox7 deficiency can be observed. We show that while Sox7 is expressed at the onset of endothelial specification from mesoderm, Sox7 deficiency does not impact the emergence of the first endothelial progenitors. However, by E8.5, clear signs of defective vascular development are already observed with the presence of highly unorganised endothelial cords rather than distinct paired dorsal aorta. By E10.5, both Sox7 complete knockout and FLK1-specific deletion of Sox7 lead to widespread vascular defects. In contrast, while SOX7 is expressed in the earliest specified blood progenitors, the VAV-specific deletion of Sox7 does not affect the hematopoietic system. Together, our data reveal the unique role of SOX7 in vasculogenesis and angiogenesis during embryonic development.

Indexed as

AnimalsCell DifferentiationEmbryonic DevelopmentFemaleGene DeletionGene Expression Regulation, DevelopmentalMesodermMiceMice, KnockoutMorphogenesisNeovascularization, PhysiologicPregnancySOXF Transcription FactorsVascular Endothelial Growth Factor Receptor-2Sox7 protein, mouseSOXF Transcription FactorsVascular Endothelial Growth Factor Receptor-2EndotheliumSOXFVascular development

Identifiers

PMID28577909
PMCPMC5496588
OpenAlexW2621036355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.